GOLDSMITH MARK A
SEC CIK 1246842 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| RVMD | Revolution Medicines, Inc. | See Remarks, Dir | 253.3K | — | $71.04M | 69 | 2021-09-17 | 2026-09-16 |
Most active insiders at RVMD, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | GOLDSMITH MARK A | See Remarks, Dir | — | $56.99M |
| 2 | Kelsey Stephen Michael | See Remarks | — | $22.55M |
| 3 | Cislini Jeff | SVP, GC | — | $15.19M |
| 4 | Kim Lorence H. | Dir | — | $14.97M |
| 5 | Horn Margaret A | COO | — | $10.84M |
| 6 | Mancini Anthony | See Remarks | — | $9.05M |
| 7 | Anders Jack | CFO | — | $7.13M |
| 8 | ANDERSON ELIZABETH M | Dir | — | $1.96M |
| 9 | Patel Sushil | Dir | — | $1.05M |
| 10 | Wei Lin | Chief Medical Off | — | $206.2K |
Transactions 69
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MT | 2026-09-18 18:02 | 2026-09-16 | RVMD | Revolution Medicines, Inc. | GOLDSMITH MARK A | See Remarks, Dir | S - Sale | $199.24 | -14.0K | 253.3K | -5% | -$2.79M |
| DT | 2026-08-25 16:06 | 2026-08-21 | RVMD | Revolution Medicines, Inc. | GOLDSMITH MARK A | See Remarks, Dir | M - OptEx | $4.73 | +80.0K | 347.3K | +30% | +$378.4K |
| DMT | 2026-08-25 16:06 | 2026-08-21 | RVMD | Revolution Medicines, Inc. | GOLDSMITH MARK A | See Remarks, Dir | S - Sale+OE | $209.20 | -80.0K | 267.3K | -23% | -$16.74M |
| DMTI | 2026-08-25 16:06 | 2026-08-21 | RVMD | Revolution Medicines, Inc. | GOLDSMITH MARK A | See Remarks, Dir | S - Sale+OE | $209.20 | -6,000 | 61.4K | -9% | -$1.26M |
| T | 2026-06-18 16:11 | 2026-06-16 | RVMD | Revolution Medicines, Inc. | GOLDSMITH MARK A | See Remarks, Dir | S - Sale | $156.12 | -10.0K | 267.3K | -4% | -$1.56M |
| DMT | 2026-04-17 19:26 | 2026-04-15 | RVMD | Revolution Medicines, Inc. | GOLDSMITH MARK A | See Remarks, Dir | M - OptEx | $4.61 | +120.0K | 396.7K | +43% | +$552.7K |
| DT | 2026-04-17 19:26 | 2026-04-15 | RVMD | Revolution Medicines, Inc. | GOLDSMITH MARK A | See Remarks, Dir | S - Sale+OE | $150.09 | -120.0K | 276.7K | -30% | -$18.01M |
| T | 2026-03-19 | 2026-03-17 | RVMD | Revolution Medicines, Inc. | GOLDSMITH MARK A | See Remarks, Dir | S - Sale | $99.48 | -12.9K | 276.7K | -4% | -$1.28M |
| DMT | 2026-03-03 | 2026-03-02 | RVMD | Revolution Medicines, Inc. | GOLDSMITH MARK A | See Remarks, Dir | S - Sale+OE | $101.22 | -30.0K | 289.6K | -9% | -$3.04M |
| DT | 2026-03-03 | 2026-03-01 | RVMD | Revolution Medicines, Inc. | GOLDSMITH MARK A | See Remarks, Dir | A - Grant | $0.00 | +57.1K | 289.6K | +25% | $0 |
| DMTI | 2026-03-03 | 2026-03-02 | RVMD | Revolution Medicines, Inc. | GOLDSMITH MARK A | See Remarks, Dir | S - Sale+OE | $101.29 | -6,000 | 64.4K | -9% | -$607.8K |
| DT | 2026-03-03 | 2026-03-02 | RVMD | Revolution Medicines, Inc. | GOLDSMITH MARK A | See Remarks, Dir | M - OptEx | $4.09 | +30.0K | 319.6K | +10% | +$122.7K |
| D | 2026-02-10 | 2026-02-06 | RVMD | Revolution Medicines, Inc. | GOLDSMITH MARK A | See Remarks, Dir | M - OptEx | $0.54 | +24.0K | 256.5K | +10% | +$13.0K |
| T | 2025-12-18 | 2025-12-16 | RVMD | Revolution Medicines, Inc. | GOLDSMITH MARK A | See Remarks, Dir | S - Sale | $76.82 | -15.4K | 232.5K | -6% | -$1.18M |
| DT | 2025-11-26 | 2025-11-25 | RVMD | Revolution Medicines, Inc. | GOLDSMITH MARK A | See Remarks, Dir | M - OptEx | $4.09 | +60.0K | 307.9K | +24% | +$245.4K |
| DT | 2025-11-26 | 2025-11-25 | RVMD | Revolution Medicines, Inc. | GOLDSMITH MARK A | See Remarks, Dir | S - Sale+OE | $75.08 | -60.0K | 247.9K | -19% | -$4.50M |
| DMTI | 2025-11-26 | 2025-11-25 | RVMD | Revolution Medicines, Inc. | GOLDSMITH MARK A | See Remarks, Dir | S - Sale+OE | $75.00 | -6,000 | 67.4K | -8% | -$450.0K |
| DT | 2025-11-20 | 2025-11-18 | RVMD | Revolution Medicines, Inc. | GOLDSMITH MARK A | See Remarks, Dir | S - Sale+OE | $70.38 | -20.0K | 247.9K | -7% | -$1.41M |
| DT | 2025-11-20 | 2025-11-18 | RVMD | Revolution Medicines, Inc. | GOLDSMITH MARK A | See Remarks, Dir | M - OptEx | $4.09 | +20.0K | 267.9K | +8% | +$81.8K |
| DT | 2025-11-14 | 2025-11-12 | RVMD | Revolution Medicines, Inc. | GOLDSMITH MARK A | See Remarks, Dir | S - Sale+OE | $65.07 | -20.0K | 247.9K | -7% | -$1.30M |
| DT | 2025-11-14 | 2025-11-12 | RVMD | Revolution Medicines, Inc. | GOLDSMITH MARK A | See Remarks, Dir | M - OptEx | $4.09 | +20.0K | 267.9K | +8% | +$81.8K |
| DMT | 2025-11-12 | 2025-11-12 | RVMD | Revolution Medicines, Inc. | GOLDSMITH MARK A | See Remarks, Dir | G - Gift | $0.00 | -100.0K | 247.9K | -29% | $0 |
| DMTI | 2025-11-12 | 2025-11-12 | RVMD | Revolution Medicines, Inc. | GOLDSMITH MARK A | See Remarks, Dir | G - Gift | $0.00 | +100.0K | 54.5K | New | $0 |
| DT | 2025-11-12 | 2025-11-07 | RVMD | Revolution Medicines, Inc. | GOLDSMITH MARK A | See Remarks, Dir | S - Sale+OE | $60.31 | -30.0K | 347.9K | -8% | -$1.81M |
| DMT | 2025-11-12 | 2025-11-07 | RVMD | Revolution Medicines, Inc. | GOLDSMITH MARK A | See Remarks, Dir | M - OptEx | $1.47 | +30.0K | 377.9K | +9% | +$44.1K |
| DMT | 2025-10-20 | 2025-10-16+ | RVMD | Revolution Medicines, Inc. | GOLDSMITH MARK A | See Remarks, Dir | M - OptEx | $1.12 | +20.0K | 462.3K | +5% | +$22.4K |
| DMT | 2025-10-20 | 2025-10-16+ | RVMD | Revolution Medicines, Inc. | GOLDSMITH MARK A | See Remarks, Dir | S - Sale+OE | $52.73 | -20.0K | 452.3K | -4% | -$1.05M |
| T | 2025-09-18 | 2025-09-16 | RVMD | Revolution Medicines, Inc. | GOLDSMITH MARK A | See Remarks, Dir | S - Sale | $45.82 | -13.4K | 452.3K | -3% | -$614.5K |
| D | 2025-07-02 | 2025-06-30 | RVMD | Revolution Medicines, Inc. | GOLDSMITH MARK A | See Remarks, Dir | M - OptEx | $0.54 | +37.0K | 465.7K | +9% | +$20.0K |
| T | 2025-06-18 | 2025-06-16 | RVMD | Revolution Medicines, Inc. | GOLDSMITH MARK A | See Remarks, Dir | S - Sale | $39.83 | -13.5K | 428.7K | -3% | -$537.5K |
| T | 2025-03-19 | 2025-03-17 | RVMD | Revolution Medicines, Inc. | GOLDSMITH MARK A | See Remarks, Dir | S - Sale | $39.04 | -11.7K | 441.6K | -3% | -$458.3K |
| D | 2025-03-04 | 2025-03-01 | RVMD | Revolution Medicines, Inc. | GOLDSMITH MARK A | See Remarks, Dir | A - Grant | $0.00 | +97.4K | 453.3K | +27% | $0 |
| D | 2024-12-20 | 2024-12-18 | RVMD | Revolution Medicines, Inc. | GOLDSMITH MARK A | See Remarks, Dir | M - OptEx | $0.49 | +30.8K | 355.9K | +9% | +$15.1K |
| T | 2024-12-18 | 2024-12-16 | RVMD | Revolution Medicines, Inc. | GOLDSMITH MARK A | See Remarks, Dir | S - Sale | $45.40 | -11.7K | 325.1K | -3% | -$531.8K |
| DMT | 2024-11-05 | 2024-11-01+ | RVMD | Revolution Medicines, Inc. | GOLDSMITH MARK A | See Remarks, Dir | M - OptEx | $2.73 | +96.6K | 309.3K | +45% | +$263.3K |
| DMT | 2024-11-05 | 2024-11-01+ | RVMD | Revolution Medicines, Inc. | GOLDSMITH MARK A | See Remarks, Dir | S - Sale+OE | $55.48 | -60.0K | 300.2K | -17% | -$3.33M |
| DMTI | 2024-11-05 | 2024-11-01 | RVMD | Revolution Medicines, Inc. | GOLDSMITH MARK A | See Remarks, Dir | S - Sale+OE | $55.02 | -10.0K | 20.4K | -33% | -$550.2K |
| DT | 2024-10-15 | 2024-10-11 | RVMD | Revolution Medicines, Inc. | GOLDSMITH MARK A | See Remarks, Dir | M - OptEx | $4.09 | +30.0K | 330.2K | +10% | +$122.7K |
| DT | 2024-10-15 | 2024-10-11 | RVMD | Revolution Medicines, Inc. | GOLDSMITH MARK A | See Remarks, Dir | S - Sale+OE | $50.36 | -30.0K | 300.2K | -9% | -$1.51M |
| DT | 2024-10-03 | 2024-10-01 | RVMD | Revolution Medicines, Inc. | GOLDSMITH MARK A | See Remarks, Dir | M - OptEx | $4.09 | +10.0K | 310.2K | +3% | +$40.9K |
| DMT | 2024-10-03 | 2024-10-01 | RVMD | Revolution Medicines, Inc. | GOLDSMITH MARK A | See Remarks, Dir | S - Sale+OE | $44.93 | -10.0K | 302.2K | -3% | -$449.3K |
| T | 2024-09-18 | 2024-09-16 | RVMD | Revolution Medicines, Inc. | GOLDSMITH MARK A | See Remarks, Dir | S - Sale | $44.19 | -11.7K | 300.2K | -4% | -$517.7K |
| DT | 2024-08-02 | 2024-08-01 | RVMD | Revolution Medicines, Inc. | GOLDSMITH MARK A | See Remarks, Dir | M - OptEx | $4.09 | +10.0K | 321.9K | +3% | +$40.9K |
| DMT | 2024-08-02 | 2024-08-01 | RVMD | Revolution Medicines, Inc. | GOLDSMITH MARK A | See Remarks, Dir | S - Sale+OE | $45.88 | -10.0K | 311.9K | -3% | -$458.8K |
| DMTI | 2024-07-16 | 2024-07-12 | RVMD | Revolution Medicines, Inc. | GOLDSMITH MARK A | See Remarks, Dir | S - Sale+OE | $45.01 | -10.0K | 25.4K | -28% | -$450.1K |
| DT | 2024-07-16 | 2024-07-12 | RVMD | Revolution Medicines, Inc. | GOLDSMITH MARK A | See Remarks, Dir | S - Sale+OE | $45.05 | -25.0K | 311.9K | -7% | -$1.13M |
| DT | 2024-07-16 | 2024-07-12 | RVMD | Revolution Medicines, Inc. | GOLDSMITH MARK A | See Remarks, Dir | M - OptEx | $4.09 | +25.0K | 336.9K | +8% | +$102.2K |
| T | 2024-06-20 | 2024-06-17 | RVMD | Revolution Medicines, Inc. | GOLDSMITH MARK A | See Remarks, Dir | S - Sale | $37.39 | -11.9K | 311.9K | -4% | -$446.8K |
| DT | 2024-06-05 | 2024-06-03 | RVMD | Revolution Medicines, Inc. | GOLDSMITH MARK A | See Remarks, Dir | M - OptEx | $4.09 | +7,500 | 329.8K | +2% | +$30.7K |
| DMT | 2024-06-05 | 2024-06-03 | RVMD | Revolution Medicines, Inc. | GOLDSMITH MARK A | See Remarks, Dir | S - Sale+OE | $39.99 | -7,500 | 328.9K | -2% | -$300.0K |
| MTI | 2024-04-12 | 2024-04-10 | RVMD | Revolution Medicines, Inc. | GOLDSMITH MARK A | See Remarks, Dir | S - Sale | $35.34 | -10.0K | 30.4K | -25% | -$353.4K |
| T | 2024-04-12 | 2024-04-10 | RVMD | Revolution Medicines, Inc. | GOLDSMITH MARK A | See Remarks, Dir | S - Sale | $35.48 | -7,500 | 452.9K | -2% | -$266.1K |
| T | 2024-03-20 | 2024-03-18 | RVMD | Revolution Medicines, Inc. | GOLDSMITH MARK A | See Remarks, Dir | S - Sale | $31.58 | -5,788 | 460.4K | -1% | -$182.8K |
| D | 2024-03-05 | 2024-03-01 | RVMD | Revolution Medicines, Inc. | GOLDSMITH MARK A | See Remarks, Dir | A - Grant | $0.00 | -90.0K | 466.2K | -16% | $0 |
| T | 2023-12-20 | 2023-12-18 | RVMD | Revolution Medicines, Inc. | GOLDSMITH MARK A | See Remarks, Dir | S - Sale | $25.90 | -8,165 | 376.2K | -2% | -$211.5K |
| D | 2023-10-24 | 2023-10-24 | RVMD | Revolution Medicines, Inc. | GOLDSMITH MARK A | See Remarks, Dir | M - OptEx | $0.49 | +35.0K | 384.3K | +10% | +$17.1K |
| 2023-09-20 | 2023-09-18 | RVMD | Revolution Medicines, Inc. | GOLDSMITH MARK A | See Remarks, Dir | S - Sale | $31.31 | -8,054 | 349.3K | -2% | -$252.2K | |
| DM | 2023-09-06 | 2023-09-01 | RVMD | Revolution Medicines, Inc. | GOLDSMITH MARK A | See Remarks, Dir | M - OptEx | $0.7721 | +30.0K | 387.4K | +8% | +$23.2K |
| D | 2023-09-06 | 2023-09-01 | RVMD | Revolution Medicines, Inc. | GOLDSMITH MARK A | See Remarks, Dir | S - Sale+OE | $35.05 | -30.0K | 357.4K | -8% | -$1.05M |
| DMI | 2023-09-06 | 2023-09-01 | RVMD | Revolution Medicines, Inc. | GOLDSMITH MARK A | See Remarks, Dir | S - Sale+OE | $35.04 | -10.0K | 35.4K | -22% | -$350.4K |
| D | 2023-03-03 | 2023-03-01 | RVMD | Revolution Medicines, Inc. | GOLDSMITH MARK A | See Remarks, Dir | A - Grant | $0.00 | +104.0K | 355.9K | +41% | $0 |
| D | 2023-02-23 | 2023-02-22 | RVMD | Revolution Medicines, Inc. | GOLDSMITH MARK A | See Remarks, Dir | M - OptEx | $0.49 | +45.0K | 251.9K | +22% | +$22.1K |
| D | 2022-08-15 | 2022-08-11 | RVMD | Revolution Medicines, Inc. | GOLDSMITH MARK A | See Remarks, Dir | M - OptEx | $0.49 | +10.0K | 206.9K | +5% | +$4,900 |
| D | 2022-08-10 | 2022-08-09 | RVMD | Revolution Medicines, Inc. | GOLDSMITH MARK A | See Remarks, Dir | M - OptEx | $0.49 | +10.3K | 196.9K | +6% | +$5,065 |
| 2022-03-21 | 2022-03-17 | RVMD | Revolution Medicines, Inc. | GOLDSMITH MARK A | See Remarks, Dir | S - Sale | $18.61 | -1,023 | 185.6K | -0.5% | -$19.0K | |
| D | 2022-03-03 | 2022-03-01 | RVMD | Revolution Medicines, Inc. | GOLDSMITH MARK A | See Remarks, Dir | A - Grant | $0.00 | +104.0K | 186.6K | +126% | $0 |
| 2021-12-21 | 2021-12-17 | RVMD | Revolution Medicines, Inc. | GOLDSMITH MARK A | See Remarks, Dir | S - Sale | $24.41 | -1,571 | 82.6K | -2% | -$38.3K | |
| D | 2021-12-08 | 2021-12-06 | RVMD | Revolution Medicines, Inc. | GOLDSMITH MARK A | See Remarks, Dir | M - OptEx | $0.49 | +37.7K | 84.2K | +81% | +$18.5K |
| 2021-09-21 | 2021-09-17 | RVMD | Revolution Medicines, Inc. | GOLDSMITH MARK A | See Remarks, Dir | S - Sale | $30.02 | -1,531 | 46.5K | -3% | -$46.0K |
Purchase Sale Sale after option exercise All abbreviations